Septa Powder for Suspension is a 125 mg/5 ml cephradine antibiotic from Doctor's Chemicals Works Ltd. It is a first-generation cephalosporin used for bacterial infections; the doctor decides the dose and course.
There are 228 brands of Cephradine listed in Bangladesh. 117 of them have a lower unit price than Septa. The lowest listed price is Belocef 500 mg Capsule at ৳ 1 per unit.
What is Septa 125 mg/5 ml Powder For Suspension?
Septa Powder for Suspension is a first-generation cephalosporin antibiotic with the active ingredient cephradine, supplied as a 125 mg/5 ml powder that is mixed into a suspension. It is prescribed for infections caused by bacteria that are sensitive to cephradine, including some infections of the upper and lower respiratory tract, such as sinusitis, pharyngitis, tonsillitis, otitis media, bronchitis and lobar pneumonia. Because it is an antibiotic, it should only be used on a registered physician's prescription. The doctor decides the dose, how often it is taken and for how long.
Uses of Septa
Septa is used to treat infections caused by bacteria that are sensitive to cephradine. These include certain upper respiratory tract infections such as sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, as well as lower respiratory tract infections including acute and chronic bronchitis and lobar pneumonia. It is not for viral illnesses such as the common cold. Your doctor will decide whether this antibiotic is suitable for your infection.
How to use Septa
Septa is an oral suspension that is prepared by mixing the powder as directed. It is taken by mouth; the doctor decides the dose, how often it is taken and the length of the course, so follow the prescription exactly. Do not change the dose or stop early without asking the doctor. The prepared suspension should be used within the time stated on the label or by the pharmacist, and any leftover medicine should be handled as advised.
Side effects of Septa
Side effects mainly involve the stomach and gut, such as nausea, vomiting, diarrhoea, abdominal pain, heartburn and, rarely, glossitis. Hypersensitivity reactions can occur, including skin rashes, urticaria, joint pains and swelling, and these are more likely in people with a history of allergy, asthma, hay fever or urticaria. Dizziness and tightness in the chest have been reported rarely. Call the doctor if you notice a rash, swelling, breathing trouble or severe diarrhoea.
Safety and precautions
Do not use Septa if you are allergic to cephalosporins. Tell your doctor if you are allergic to penicillins, because cross-sensitivity between beta-lactam antibiotics is possible. Safety in pregnancy has not been established, and cephradine passes into breast milk, so pregnant or breastfeeding women should ask their doctor first. People with kidney problems, or those taking other medicines, including diuretics or nephrotoxic drugs, should check with the doctor. Because dizziness may occur, be careful with driving and machinery. Keep all medicines out of the reach of children.
Frequently asked questions
What is Septa used for and what kind of medicine is it?
Septa is a first-generation cephalosporin antibiotic containing cephradine. It is used for certain bacterial infections of the upper and lower respiratory tract, such as sinusitis, tonsillitis, otitis media, bronchitis and lobar pneumonia. It does not treat viral infections, so the doctor decides if it is suitable.
How should Septa be taken?
Septa is an oral suspension taken by mouth after the powder is mixed as directed. The doctor decides the dose, how often it is taken and how long the course lasts, so follow the prescription exactly. Ask the doctor or pharmacist if you are unsure about how to take it.
What side effects should I watch for, and when should I call the doctor?
Watch for stomach upset such as nausea, vomiting, diarrhoea or abdominal pain, and for skin rash, swelling, joint pains or dizziness. Call the doctor promptly if you develop a rash, swelling, breathing trouble or severe diarrhoea, or if any side effect worries you.
Cephradine is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include-
Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also
... Read more
Cephradine is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include-
Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also
Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.
Urinary tract infections: cystitis, urethritis and pyelonephritis.
Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.
The following microorganisms are susceptible, in vitro to Cephradine:
Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.
Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Cephradine which is unaffected by this enzyme.
Pharmacology
Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.
Dosage & Administration
For oral administration- Adults:
Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.
Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.
Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.
Children:
Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.
Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.
Maximum daily dosage: 4 gm
Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.
For injectable administration-
Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.
Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection.
Interaction
The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.
Contraindications
Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.
Side Effects
Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.
Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)
Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis
Renal and urinary disorders- Unknown: Reversible interstitial nephritis
Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase.
Pregnancy & Lactation
Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.
Precautions & Warnings
Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.
Cephradine should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.
Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.
Cephradine may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).
Dosage adjustment is necessary in renal impairment.
This product contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Overdose Effects
The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.
Storage Conditions
Cephradine Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Cephradine Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician
Alternative brands of Cephradine
Other brands with the same generic name, cheapest first.